We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

84 hedge funds and large institutions have $98.7M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 15

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

15% more capital invested

Capital invested by funds: $85.8M → $98.7M (+$12.8M)

6% more funds holding

Funds holding: 79 → 84 (+5)

0.6% more ownership

Funds ownership: 26.83% → 27.44% (+0.6%)

Holders
84
Holders Change
+5
Holders Change %
+6.33%
% of All Funds
1.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
31
Reduced
15
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCS
Retirement Capital Strategies
California
+$3.97M
2
WBG
Wharton Business Group
Pennsylvania
+$2.07M
3
CPC
Congress Park Capital
New York
+$1.02M
4
WAP
Wealthcare Advisory Partners
Pennsylvania
+$962K
5
Morgan Stanley
Morgan Stanley
New York
+$929K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$8.21M
2
OWA
Outlook Wealth Advisors
Texas
-$747K
3
Bank of America
Bank of America
North Carolina
-$353K
4
FTUS
Flow Traders U.S.
New York
-$336K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
-$247K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
51
IFP Advisors
Florida
$209K – – –
VWM
52
Venturi Wealth Management
Texas
$202K +$182K +3,874 New
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$107K +$97.2K +2,070 New
NFG
54
Next Financial Group
Texas
$56K – – –
Simplex Trading
55
Simplex Trading
Illinois
$55K +$8.54K +182 +21%
AIC
56
Archer Investment Corporation
Indiana
$52K – – –
HWA
57
HHM Wealth Advisors
Tennessee
$52K – – –
FPW
58
Flagship Private Wealth
Massachusetts
$48.2K +$43.3K +923 +2,007%
TCM
59
TD Capital Management
Tennessee
$47K +$1.92K +41 +5%
CAPTRUST Financial Advisors
60
CAPTRUST Financial Advisors
North Carolina
$46K +$16.5K +352 +67%
PNC Financial Services Group
61
PNC Financial Services Group
Pennsylvania
$35K +$8.92K +190 +39%
Fidelity Investments
62
Fidelity Investments
Massachusetts
$34K -$2.77K -59 -8%
AP
63
Atwood & Palmer
Missouri
$28K – – –
HI
64
Harbour Investments
Wisconsin
$27K – – –
Northwestern Mutual Wealth Management
65
Northwestern Mutual Wealth Management
Wisconsin
$25K +$22.4K +477 New
BCV
66
Banque Cantonale Vaudoise
Switzerland
$23K +$20.7K +440 New
EIP
67
Ellis Investment Partners
Pennsylvania
$22K +$14.1K +300 +231%
Citigroup
68
Citigroup
New York
$21K – – –
TF
69
TimeScale Financial
Massachusetts
$21K – – –
APA
70
American Portfolios Advisors
New York
$19.5K – – –
CB
71
Community Bank
New York
$18K – – –
KTC
72
Kistler-Tiffany Companies
Pennsylvania
$18K – – –
SWM
73
Sugarloaf Wealth Management
Georgia
$16K -$98.9K -2,108 -87%
NSIM
74
North Star Investment Management
Illinois
$16K – – –
GEA
75
Glen Eagle Advisors
New Jersey
$15.6K – – –
1 2
3
4

IDNA Hedge Fund Activity: Q2 2021 in Review

84 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q2 2021, worth a combined $98.7M — up 15% from $85.8M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new IDNA positions and 8 closed out — a net gain of 5 holders — while 31 added to existing stakes and 15 trimmed.

The largest buyer was Retirement Capital Strategies, adding an estimated $3.97M. The largest seller was Jane Street, cutting an estimated $8.21M.

  • 84 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q2 2021, up from 79 in Q1 2021.
  • Funds reported $98.7M of iShares Genomics Immunology and Healthcare ETF stock for Q2 2021, up 15% quarter-over-quarter.
  • 13 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q2 2021 and 8 closed out, a net change of +5 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q2 2021 was Retirement Capital Strategies, an estimated $3.97M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q2 2021 was Jane Street, an estimated $8.21M sold.

Based on aggregated 13F filings for Q2 2021.